CANCER DETECTION

CANCER DETECTION:
The Liquid Biopsy Breakthrough
SC 203

Liquid biopsies, also known as fluid biopsy or fluid phase biopsy, are non-invasive alternatives to surgical biopsies which provide information about disease processes (such as cancer) through a simple blood draw. Because it can be performed more frequently than surgical procedures, it can better track tumors and mutations over time. Liquid biopsy of circulating tumor cells has been recently validated and approved by the FDA. This presentation will cover the factors responsible for its tremendous growth in the past few years and its importance in diagnosing and even predicting various cancers by measuring DNA fragments in blood.

Presenter/Developer: Vern Roohk, Ph.D.,
Physiology and Biochemistry, UC Davis, and OLLI STEM Committee member.

Wednesday, March 13
12:00 Noon – 2:00 PM

Facilitators:
Sara Schoenfelder 949-854-7699
sara.schoenfelder@cox.net

Eileen Thiessen 714-838-4488
ethiessen@cox.net